{{Rsnum
|rsid=266882
|Gene=KLK3
|Chromosome=19
|position=50854757
|Orientation=plus
|GMAF=0.3967
|Gene_s=KLK3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{PMID Auto
|PMID=23235975
|Title=Association of G/A Polymorphism, rs266882, in AREI Region of the Prostate-Specific Antigen Gene with Prostate Cancer Risk and Clinicopathological Features
}}

{{PMID Auto
|PMID=16775173
|Title=Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
}}

{{PMID Auto
|PMID=18336535
|Title=Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
}}

{{PMID Auto
|PMID=18768516
|Title=Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.
}}

{{PMID Auto
|PMID=18827812
|Title=Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels.
|OA=1
}}

{{PMID Auto
|PMID=19823874
|Title=A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.
|OA=1
}}

{{PMID Auto
|PMID=21787114
|Title=Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.
}}

{{PMID Auto
|PMID=23315126
|Title=Contribution of genetic variation rs266882 to prostate-specific antigen levels in healthy controls with serum PSA below 2.0 ng/ml.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}